Physician profile
Sathya Bhandari
NPI 1356419980
$108,275.41
in general payments reported to CMS, 2019-2025
34 companies · $46K in 2025
The $46K reported for 2025 was more than what 99% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,523 · 2020: $247 · 2021: $365 · 2022: $1,966 · 2023: $9,347 · 2024: $46K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $79K · Travel and Lodging: $10K · Food and Beverage: $7,325 · Consulting Fee: $5,500 · Education: $61.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $79,250.00 |
| Travel and Lodging | $10,037.32 |
| Food and Beverage | $7,324.99 |
| Consulting Fee | $5,500.00 |
| Education | $61.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $100,922.37 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, Intracept |
| Vertiflex, INC. | $1,041.23 | 2019 | |
| Abbott Laboratories | $1,031.71 | 2019-2025 | Eterna, Proclaim |
| Nevro Corp. | $864.53 | 2019-2024 | Senza |
| Spinal Simplicity, LLC | $673.37 | 2022-2025 | Ha Minuteman G3-R |
| Saluda Medical Americas, INC. | $604.44 | 2023-2025 | Evoke, Evoke Scs |
| Si-Bone, INC. | $394.10 | 2022-2025 | |
| Abbvie INC. | $370.36 | 2021-2025 | Botox, Qulipta, Ubrelvy |
| Curonix LLC | $347.91 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $292.02 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $228.83 | 2021-2025 | Xtampza, Belbuca |
| Sentynl Therapeutics, INC. | $212.41 | 2019-2020 | |
| Stryker Corporation | $193.41 | 2022-2025 | Mild Device Kit |
| Pfizer INC. | $183.40 | 2023-2025 | |
| Lundbeck LLC | $133.25 | 2023-2025 | Vyepti |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $128.82 | 2021-2025 | Ztlido |
| Azurity Pharmaceuticals, INC. | $104.93 | 2023-2025 | Horizant, Horizant |
| Medtronic, INC. | $83.22 | 2021-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Avanos Medical | $53.01 | 2021-2024 | Coolief* Cooled Radiofrequency |
| Lilly USA, LLC | $50.84 | 2019-2023 | Emgality, Reyvow |
| Spr Therapeutics, INC | $47.65 | 2019-2024 | Sprint Pns System |
| Averitas Pharma INC. | $45.60 | 2024 | Qutenza |
| Arbor Pharmaceuticals, INC. | $44.10 | 2020-2022 | |
| Allergan, INC. | $40.22 | 2020-2022 | |
| Bioventus LLC | $39.39 | 2022-2023 | Durolane |
| Almatica Pharma LLC | $26.39 | 2021-2022 | |
| Hydrocision, INC. | $21.29 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.59 | 2024 | Relistor |
| Horizon Therapeutics Plc | $16.80 | 2021 | |
| Tonix Medicines, INC. | $16.34 | 2025 | Tonmya |
| Kowa Pharmaceuticals America, INC. | $14.56 | 2022 | |
| Currax Pharmaceuticals LLC | $14.28 | 2024 | Onzetra Xsail |
| Novartis Pharmaceuticals Corporation | $12.32 | 2019 | |
| Forte Bio-Pharma LLC | $4.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sathya Bhandari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.